Limitations of current treatment
Open Access
- 1 October 1997
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 350, S24-S27
- https://doi.org/10.1016/s0140-6736(97)90033-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Dietary fat and asthma: is there a connection?European Respiratory Journal, 1997
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- A potential vaccine strategy for asthma and allied atopic diseases during early childhoodThe Lancet, 1994
- Increase in asthma: a more toxic environment or a more susceptible population?Thorax, 1994
- A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate AsthmaNew England Journal of Medicine, 1992
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990
- THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITYThe Lancet, 1983
- Mortality from asthma: a new epidemic in New ZealandBMJ, 1982
- RISE AND FALL OF ASTHMA MORTALITY IN ENGLAND AND WALES IN RELATION TO USE OF PRESSURISED AEROSOLSThe Lancet, 1969